S. Sokolov

发表

Autonomic nervous modulation after cryoballoon ablation for paroxysmal atrial fibrillation

M. Shariya, E. Maykov, P. Novikov, 2021, Journal of Arrhythmology.

[Potential risk factors of atrial fibrillation recurrence after cryoballoon ablation].

M. Shariya, E. Maykov, P. Novikov, 2022, Kardiologiia.

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety

D. S. Parkhomchuk, S. Golitsyn, N. Mironov, 2021, Rational Pharmacotherapy in Cardiology.

The potential and limitations of standard electrocardiography for the differential diagnosis of wide QRS complex tachycardias

N. Shlevkov, H. Salami, S. Sokolov, 2019, Almanac of Clinical Medicine.

[Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation].

N. Mironova, S. Golitsyn, N. Mironov, 2021, Terapevticheskii arkhiv.

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness

D. S. Parkhomchuk, R. Batalov, S. Golitsyn, 2021 .

Efficacy of a New Class III Drug Niferidil in Cardioversion of Persistent Atrial Fibrillation and Flutter

E. Chazov, S. Golitsyn, L. Rosenshtraukh, 2014, Journal of cardiovascular pharmacology.

[Recent advances in diagnosis and management of atrial fibrillation].

S. Golitsyn, E. Maykov, I. Novikov, 2019, Терапевтический архив.

Clinical experience of new antiarrhythmic drug refralon for pharmacological cardioversion in patients with atrial fibrillation after pulmonary vein cryoablation

N. Mironova, S. Golitsyn, M. A. Zelberg, 2021, Journal of Arrhythmology.